Associated Papers
Clinical exome sequencing identifies novel compound heterozygous mutations of the POMT2 gene in patients with limb-girdle muscular dystrophy.
Zhao X et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience, 2023
[A Japanese family with POMT2-related limb girdle muscular dystrophy].
Tomita Y et al.
Rinsho Shinkeigaku = Clinical Neurology, 2021
Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness.
Töpf A et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020
32528171 (PubMed )
Supplement: 41436_2020_840_MOESM10_ESM.xlsx › .
Structure of the eukaryotic protein O-mannosyltransferase Pmt1-Pmt2 complex.
Bai L et al.
Nature Structural & Molecular Biology, 2019
31285605 (PubMed )
Supplement: NIHMS1530499-supplement-2.pdf
Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness.
Johnson K et al.
Skeletal Muscle, 2018
Limb girdle muscular dystrophy due to mutations in POMT2.
Østergaard ST et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2018
[Limb-girdle muscular dystrophy; update].
Sunada Y
Rinsho Shinkeigaku = Clinical Neurology, 2004
[A family with oculopharyngeal muscular dystrophy with (GCG)9 expansion in which a sister had neck as well as proximal and her brother proximal lower limb muscle weakness].
Takahashi T et al.
Rinsho Shinkeigaku = Clinical Neurology, 2000
[Staircase phenomenon in "mitochodrial myopathy' and limb-girdle type muscular dystrophy].
Sunohara N et al.
Rinsho Shinkeigaku = Clinical Neurology, 1982
Select a paper to view details